The Whizz improves the management of respiratory conditions by increasing the efficiency of medication delivered into the lungs while tracking intake data to augment the assessment of treatment outcomes. The Whizz spacer helps deliver medication effectively to patients, paired with a mobile application that has multiple features to track and encourage compliance through gamification and manage treatment regimens.
Meracle successfully created an iOS version of the Whizz mobile application and was seeking a partner to build a version that runs on Android devices. In late 2023 and 2024, Meracle potentially planned to expand into the European, Japanese, and Taiwanese markets. This must be evaluated while creating the new application.